|
May 3
|
Bausch + Lomb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 1
|
Bausch & Lomb Corp (BLCO) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Net Loss Widening
|
|
May 1
|
Bausch + Lomb Announces First-Quarter 2024 Results
|
|
Apr 29
|
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
|
|
Apr 25
|
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
|
|
Apr 18
|
Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs
|
|
Apr 15
|
Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
|
|
Mar 27
|
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting
|
|
Nov 28
|
Bausch + Lomb CEO Brent Saunders Pays $35.35 Million for Cher’s Former Miami Beach Home
|
|
Nov 1
|
Bausch & Lomb Corp (BLCO) Reports Q3 2023 Earnings and Raises Full-Year Guidance
|
|
Nov 1
|
Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance
|
|
Aug 29
|
Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference
|
|
Jun 30
|
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
|
|
Jun 30
|
Bausch + Lomb’s CEO Inks First Big Deal Since Return
|
|
Jun 30
|
Bausch + Lomb Will Acquire XIIDRA®
|
|
Apr 26
|
Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting
|
|
Apr 25
|
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
|
|
Apr 24
|
Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System
|